Brief: Armata Pharmaceuticals Announces Chief Executive Officer Transition
02/08/2021 12:40
Aug 2 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES CHIEF EXECUTIVE OFFICER
TRANSITION
* SAYS BRIAN VARNUM APPOINTED CEO
* ARMATA PHARMACEUTICALS - CURRENT CEO, TODD R. PATRICK, IS
RETIRING FROM DAY-TO-DAY ACTIVE MANAGEMENT OF CO
* ARMATA PHARMACEUTICALS - PATRICK WILL CONTINUE TO SERVE ON
CO'S
BOARD & AGREED TO ACT AS A SPECIAL ADVISOR TO CO THROUGH AT
LEAST 2022
Source text for Eikon: ID:nPn8Jb3rqa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles